Literature DB >> 20199512

'Normal for now' or 'at future risk': a double standard for selecting young and older living kidney donors.

R W Steiner1.   

Abstract

Transplant centers medically evaluate potential living kidney donors in part to determine their baseline remaining lifetime risk for end stage renal disease (ESRD). If baseline risk is increased by the presence of a risk factor for ESRD, donation is often refused. However, as only about 13% of ESRD occurs in the general population by age 44, a normal medical evaluation cannot be expected to significantly reduce the 7% lifetime risk for a 'normal' 25-year-old black donor or the 2-3% risk for a similar white donor. About half of newly diagnosed ESRD in the United States occurs by age 65, and about half of that is from diabetic nephropathy, which takes about 25 years to develop. Therefore, the remaining baseline lifetime risk for ESRD is significantly lower in the normal, nondiabetic 55-year-old donor candidate. Some older donors with an isolated medical abnormality such as mild hypertension will be at lower or about the same overall baseline lifetime risk for ESRD as are young 'normal' donor candidates. Transplant centers use a 'normal for now' standard for accepting young donors, in place of the long-term risk estimates that must guide selection of all donors.

Entities:  

Mesh:

Year:  2010        PMID: 20199512     DOI: 10.1111/j.1600-6143.2010.03023.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  21 in total

1.  Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study.

Authors:  Takako Saito; Keiko Uchida; Hideki Ishida; Kazunari Tanabe; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2014-11-01       Impact factor: 2.370

Review 2.  The living kidney donor evaluation: focus on renal issues.

Authors:  Ajay Kher; Didier A Mandelbrot
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

Review 3.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

4.  Living Donor Kidney Transplantation: Facilitating Education about Live Kidney Donation--Recommendations from a Consensus Conference.

Authors:  Jane C Tan; Elisa J Gordon; Mary Amanda Dew; Dianne LaPointe Rudow; Robert W Steiner; E Steve Woodle; Rebecca Hays; James R Rodrigue; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-23       Impact factor: 8.237

Review 5.  Risks and outcomes of living donation.

Authors:  Krista L Lentine; Anita Patel
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

6.  Mortality and cardiovascular disease among older live kidney donors.

Authors:  P P Reese; R D Bloom; H I Feldman; P Rosenbaum; W Wang; P Saynisch; N M Tarsi; N Mukherjee; A X Garg; A Mussell; J Shults; O Even-Shoshan; R R Townsend; J H Silber
Journal:  Am J Transplant       Date:  2014-07-09       Impact factor: 8.086

7.  Transplantation: Increased ESRD and mortality risk for kidney donors?

Authors:  Arthur J Matas
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

Review 8.  Long-term medical risks to the living kidney donor.

Authors:  Ngan N Lam; Krista L Lentine; Andrew S Levey; Bertram L Kasiske; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2015-05-05       Impact factor: 28.314

9.  Health care follow-up by live kidney donors more than three yr post-nephrectomy.

Authors:  Francis L Weng; Peter P Reese; Amy D Waterman; Angelo G Soto; Kitaw Demissie; Shamkant Mulgaonkar
Journal:  Clin Transplant       Date:  2012 May-Jun       Impact factor: 2.863

10.  The Outcomes of Living Kidney Donation from Medically Complex Donors: Implications for the Donor and the Recipient.

Authors:  Matthew Niemi; Didier A Mandelbrot
Journal:  Curr Transplant Rep       Date:  2014-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.